119 related articles for article (PubMed ID: 3147311)
1. [Improvement in cardiovascular autonomic dysfunction of a patient with OPCA with L-threo-3,4-dihydroxyphenylserine].
Fukuma A; Matsubayashi K; Kitazumi T; Otsuka K; Sadakane N; Shimada K; Ozawa T
Nihon Naika Gakkai Zasshi; 1988 Jun; 77(6):847-51. PubMed ID: 3147311
[No Abstract] [Full Text] [Related]
2. [Clinical effects of oral L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in patients with Shy-Drager syndrome].
Senda Y; Muto T; Matsuoka Y; Takahashi A; Sobue I
Rinsho Shinkeigaku; 1987 Mar; 27(3):300-4. PubMed ID: 3111772
[No Abstract] [Full Text] [Related]
3. Studies of neurocirculatory effects of long-term L-threo-3,4-dihydroxyphenylserine administration in a patient with familial amyloidotic polyneuropathy.
Azuma T; Suzuki T; Mizuno R; Tsujino S; Kishimoto S; Mizuta E; Ichikawa K
Acta Neurol Scand; 1988 May; 77(5):409-13. PubMed ID: 3137768
[TBL] [Abstract][Full Text] [Related]
4. Treatment of orthostatic hypotension in Shy-Drager syndrome with DL-threo-3,4-dihydroxyphenylserine: a case report.
Sakoda S; Suzuki T; Higa S; Ueji M; Kishimoto S; Matsumoto M; Yoneda S
Eur Neurol; 1985; 24(5):330-4. PubMed ID: 3932074
[TBL] [Abstract][Full Text] [Related]
5. [A case of diabetic orthostatic hypotension effectively managed with L-dops (L-threo-3,4-dihydroxyphenylserine)].
Yoshikawa H; Kawai K; Inoue S; Murayama Y; Kuzuya N; Fujita T; Koide Y; Yamashita K; Yoshizawa K; Mizusawa H
Nihon Naika Gakkai Zasshi; 1987 Nov; 76(11):1695-700. PubMed ID: 3151075
[No Abstract] [Full Text] [Related]
6. DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness.
Birkmayer W; Birkmayer G; Lechner H; Riederer P
J Neural Transm; 1983; 58(3-4):305-13. PubMed ID: 6420517
[TBL] [Abstract][Full Text] [Related]
7. [Clinico-pathological study of the central autonomic nervous system in idiopathic parkinsonism--in comparison with sporadic olivopontocerebellar atrophy].
Mitake S; Mizutani T
Rinsho Shinkeigaku; 1987 Apr; 27(4):472-8. PubMed ID: 3476231
[No Abstract] [Full Text] [Related]
8. Orthostatic hypotension in familial amyloid polyneuropathy: treatment with DL-threo-3,4-dihydroxyphenylserine.
Suzuki T; Higa S; Sakoda S; Hayashi A; Yamamura Y; Takaba Y; Nakajima A
Neurology; 1981 Oct; 31(10):1323-6. PubMed ID: 6287350
[TBL] [Abstract][Full Text] [Related]
9. d,l-threo-3,4-dihydroxyphenylserine restores sympathetic control and cures orthostatic hypotension in dopamine beta-hydroxylase deficiency.
Man in 't Veld AJ; Boomsma F; van den Meiracker AH; Julien C; Lenders J; Schalekamp MA
J Hypertens Suppl; 1988 Dec; 6(4):S547-9. PubMed ID: 3149290
[TBL] [Abstract][Full Text] [Related]
10. DL-Threo-3,4-dihydroxyphenylserine does not exert a pressor effect in orthostatic hypotension.
Hoeldtke RD; Cilmi KM; Mattis-Graves K
Clin Pharmacol Ther; 1984 Sep; 36(3):302-6. PubMed ID: 6432398
[TBL] [Abstract][Full Text] [Related]
11. Sympathetic skin response in patients with cerebellar degeneration.
Yokota T; Hayashi M; Tanabe H; Tsukagoshi H
Arch Neurol; 1993 Apr; 50(4):422-7. PubMed ID: 8460965
[TBL] [Abstract][Full Text] [Related]
12. The treatment of orthostatic hypotension with dihydroxyphenylserine.
Freeman R; Landsberg L
Clin Neuropharmacol; 1991 Aug; 14(4):296-304. PubMed ID: 1913697
[TBL] [Abstract][Full Text] [Related]
13. [A case with acute pandysautonomia with aseptic meningitis--Pathophysiological and therapeutic study].
Ushiyama M; Ikeda S; Yazawa M; Yanagisawa N; Takatsu M
Rinsho Shinkeigaku; 1987 Aug; 27(8):1035-42. PubMed ID: 3121228
[No Abstract] [Full Text] [Related]
14. Improved orthostatic tolerance in familial amyloidotic polyneuropathy with unnatural noradrenaline precursor L-threo-3,4-dihydroxyphenylserine.
Carvalho MJ; van den Meiracker AH; Boomsma F; Man in 't Veld AJ; Freitas J; Costa O; de Freitas AF
J Auton Nerv Syst; 1997 Jan; 62(1-2):63-71. PubMed ID: 9021651
[TBL] [Abstract][Full Text] [Related]
15. Droxidopa in neurogenic orthostatic hypotension.
Kaufmann H; Norcliffe-Kaufmann L; Palma JA
Expert Rev Cardiovasc Ther; 2015; 13(8):875-91. PubMed ID: 26092297
[TBL] [Abstract][Full Text] [Related]
16. Managing supine hypertension in a patient with non-diabetic autonomic neuropathy receiving droxidopa for neurogenic orthostatic hypotension.
Vernino S; Lew M; Kremens D
Clin Auton Res; 2017 Jul; 27(Suppl 1):35-37. PubMed ID: 28623420
[No Abstract] [Full Text] [Related]
17. Initiating droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.
Claassen D; Lew M
Clin Auton Res; 2017 Jul; 27(Suppl 1):13-14. PubMed ID: 28631224
[No Abstract] [Full Text] [Related]
18. Managing neurogenic orthostatic hypotension in a patient presenting with pure autonomic failure who later developed Parkinson disease.
Gupta F; Kremens D; Vernino S; Karabin B
Clin Auton Res; 2017 Jul; 27(Suppl 1):9-11. PubMed ID: 28699048
[No Abstract] [Full Text] [Related]
19. Effect of L-threo-3, 4-dihydroxyphenylserine on orthostatic hypotension in a patient with spinal cord injury.
Muneta S; Iwata T; Hiwada K; Murakami E; Sato Y; Imamura Y
Jpn Circ J; 1992 Mar; 56(3):243-7. PubMed ID: 1552652
[TBL] [Abstract][Full Text] [Related]
20. Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A).
Hauser RA; Hewitt LA; Isaacson S
J Parkinsons Dis; 2014; 4(1):57-65. PubMed ID: 24326693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
